Trials / Completed
CompletedNCT04579627
Facial Hair, PPE and COVID-19
How Has the Increased Use of FFP3 Style Respirators During the COVID-19 Pandemic Affected Hospital Doctor's Facial Hair? Implications for Staff Safety and Welfare.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 358 (actual)
- Sponsor
- Royal Cornwall Hospitals Trust · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
An observational cross sectional questionnaire study looking into facial hair of hospital doctors during the COVID-19 pandemic, and how personal protective equipment guidance has affected this.
Detailed description
COVID-19 is a highly contagious virus which has caused a global pandemic. There have been significant health consequences for healthcare workers, which may be related to the provision of personal protective equipment (PPE). Following PPE guidance is a significant health and safety concern, under which facial hair guidance for tight fitting masks falls. This has implications as FFP3 masks are not the only form of PPE for the face, and this study may highlight a need for employers to diversify which PPE they supply to their employees, such as full hoods if staff need to maintain facial hair for cultural or religious reasons. As such, facial hair has potential implications for patient safety, but also these have to be balanced with personal or religious reasons for maintaining facial hair. Our study aimed to determine the facial hair styles of hospital doctors, and reasons for maintaining them during the COVID-19 pandemic. We also looked at whether these styles adhered to the PPE guidance set about by Public Health England (PHE)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Questionnaire | A single survey questionnaire to staff to report their demographics and facial hair styles between January and April 2020 |
Timeline
- Start date
- 2020-05-14
- Primary completion
- 2020-06-08
- Completion
- 2020-06-08
- First posted
- 2020-10-08
- Last updated
- 2020-10-08
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04579627. Inclusion in this directory is not an endorsement.